Home » Medical Devices » Diabetes Devices Market

Diabetes Devices Market (Insulin Delivery Devices: Insulin Pumps, Insulin Syringes, Insulin Pens & Insulin Inhalers; Glucose Monitoring Devices: Glucose Test Strips, Lancing Devices and Lancets, Glucose Meters, Continuous Glucose Monitoring) – Growth, Future Prospects and Competitive Analysis, 2016 – 2022

Price: $4999

Published: | Report ID: 4251 | Report Format : PDF

The International Diabetes Foundation (IDF) reports that as of 2013, 382 Mn individuals i.e. 8.3% of the global adult population is living with diabetes, and is expected that over the next 25 years, this population would rise beyond 592 Mn. The IDF also reports that with 175 Mn diabetes cases being currently undiagnosed, a large set of diabetic population is unknowingly heading towards disease related complications, thus adding to the potential yet avoidable disease burden. Additionally, 80% of the total diabetic patient pool lives in middle- and low-income countries, where the prevalence is on a phenomenal growth.

This report on global diabetes devices studies market for devices and equipment used for monitoring and treatment of diabetes. For the purpose of this report, the diabetes devices market is segmented into insulin delivery devices and glucose monitoring devices categories. The insulin delivery devices market is classified as insulin pumps, insulin syringes, insulin pens and insulin inhalers segments. Glucose test strips, lancing devices and lancets, glucose meters and continuous glucose monitors are the glucose monitoring devices studied in this report. This report presents the market size and forecast for each device segment for the period 2014-2022, along with respective CAGRs for the forecast during 2016-2022.

Geographically, the global diabetes market is studied for the following regional markets:

North America

a.    U.S.

b.    Canada

Europe

a.    U.K.

b.    Germany

c.    Rest of Europe

Asia-Pacific

a.    Japan

b.    China

c.    Rest of Asia-Pacific

Middle East and Africa

Latin America

The market size and forecast for the period 2014-2022 along with the CAGRs for the period 2016-2022 for the mentioned segments are also presented in this study. Cumulative presentation, market size and forecast of insulin delivery devices and glucose monitoring devices for individual country level markets are also provided in this report.

Qualitative information sets such as market dynamics (drivers, challenges, future prospects) and market inclination insights are provided in this market assessment report. Tools such as competition assessment and attractive investment proposition are also included in this study for studying the global market competition. The report concludes with company profiles section that highlights key information about the major market players operating in the global diabetes devices market.

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Insulin Delivery Devices Market Share, 2015 & 2022 (Value %)
2.2 Glucose Monitoring Devices Market, 2015 (USD Mn)
2.3 Diabetes Devices Market Share, by Geography, 2015 (Value %)

Chapter 3 Diabetes Devices Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Market Positioning, by Key Market Players

Chapter 4 Global Insulin Delivery Devices Market Analysis, 2014-2022 (USD Mn)
4.1 Preface
4.2 Insulin Pumps
4.3 Insulin Syringes
4.4 Insulin Pens
4.5 Insulin Inhalers

Chapter 5 Global Glucose Monitoring Devices Market Analysis, 2014-2022 (USD Mn)
5.1 Preface
5.2 Glucose Test Strips
5.3 Lancing Devices and Lancets
5.4 Glucose Meters
5.5 Continuous Glucose Monitoring

Chapter 6 Global Diabetes Devices Market, by Geography, 2014-2022 (USD Mn)
6.1 Preface
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia-Pacific
6.4.1 Japan
6.4.2 China
6.4.3 Rest of Asia-Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America

Chapter 7 Company Profiles
7.1 Dexcom, Inc.
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Johnson & Johnson (LifeScan, Inc. and Animas Corporation)
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 Novo Nordisk
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 Abbott Laboratories
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 Roche Diagnostics
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Positions/Portfolio
7.5.4 News Coverage
7.6 Eli Lilly and Company
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product Positions/Portfolio
7.6.4 News Coverage
7.7 Bayer AG
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Positions/Portfolio
7.7.4 News Coverage
7.8 Ypsomed AG
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Positions/Portfolio
7.8.4 News Coverage
7.9 Medtronic plc
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Positions/Portfolio
7.9.4 News Coverage
7.10 Tandem Diabetes Care, Inc.
7.10.1 Business Description
7.10.2 Financial Health and Budget Allocation
7.10.3 Product Positions/Portfolio
7.10.4 News Coverage
7.11 Sanofi S.A.
7.11.1 Business Description
7.11.2 Financial Health and Budget Allocation
7.11.3 Product Positions/Portfolio
7.11.4 News Coverage
7.12 Terumo Corporation
7.12.1 Business Description
7.12.2 Financial Health and Budget Allocation
7.12.3 Product Positions/Portfolio
7.12.4 News Coverage
7.13 Other Notable Players

List of Figures

FIG. 1 Diabetes Devices: Market Segmentation
FIG. 2 Insulin Delivery Devices Market Share, 2015 & 2022 (Value %)
FIG. 3 Glucose Monitoring Devices Market, 2015 (USD Mn)
FIG. 4 Diabetes Devices Market Share, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, Diabetes Devices Market, 2015
FIG. 6 Competitive Analysis: Market Positioning, by Key Market Players
FIG. 7 Global Insulin Pumps Market, 2014 – 2022 (USD Mn)
FIG. 8 Global Insulin Syringes Market, 2014 – 2022 (USD Mn)
FIG. 9 Global Insulin Pens Market, 2014 – 2022 (USD Mn)
FIG. 10 Global Insulin Inhalers Market, 2014 – 2022 (USD Mn)
FIG. 11 Global Glucose Test Strips Market, 2014 – 2022 (USD Mn)
FIG. 12 Global Lancing Devices and Lancets Market, 2014 – 2022 (USD Mn)
FIG. 13 Global Glucose Meters Market, 2014 – 2022 (USD Mn)
FIG. 14 Global Continuous Glucose Monitoring Market, 2014 – 2022 (USD Mn)

List of Tables

TABLE 1 Global Insulin Delivery Devices Market, 2014 – 2022 (USD Mn)
TABLE 2 Global Glucose Monitoring Devices Market, 2014 – 2022 (USD Mn)
TABLE 3 Global Diabetes Devices Market, by Geography, 2014 – 2022 (USD Mn)
TABLE 4 North America Diabetes Devices Market, by Country, 2014 – 2022 (USD Mn)
TABLE 5 U.S. Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)
TABLE 6 Canada Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)
TABLE 7 Europe Diabetes Devices Market, by Country, 2014 – 2022 (USD Mn)
TABLE 8 U.K. Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)
TABLE 9 Germany Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)
TABLE 10 Rest of Europe Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)
TABLE 11 Asia-Pacific Diabetes Devices Market, by Country, 2014 – 2022 (USD Mn)
TABLE 12 Japan Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)
TABLE 13 China Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)
TABLE 14 Rest of Asia-Pacific Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)
TABLE 15 Middle East and Africa Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)
TABLE 16 Latin America Diabetes Devices Market, by Insulin Delivery and Glucose Monitoring Devices, 2014 – 2022 (USD Mn)

Frequently Asked Questions

What is the size of Diabetes Devices Market?

The market for Diabetes Devices is expected to reach US$ 592 Mn in 2022.

What is the Diabetes Devices Market CAGR?

The Diabetes Devices market is expected to see significant CAGR growth over the coming years,at 8.3%.

What is the Forecast period considered for Diabetes Devices Market?

The report is forecasted from 2016-2022.

What is the base year considered for Diabetes Devices Market?

The base year of this report is 2015.

Who are the major players in this Market?

Dexcom, Inc., Johnson & Johnson (LifeScan, Inc. and Animas Corporation), Novo Nordisk, Abbott Laboratories, Roche Diagnostics
are some of the major players in the global market.

Coronary Microcatheters Market

Published:
Report ID: 35322

Patient Positioning Systems Market

Published:
Report ID: 8794

Orthopedic Oncology Treatment Market

Published:
Report ID: 8246

Audiology Devices Market

Published:
Report ID: 2640

Cardiac Rehabilitation Devices Market

Published:
Report ID: 35105

IV Tubing Sets and Accessories Market

Published:
Report ID: 35095

Infectious Disease Diagnostic Market

Published:
Report ID: 35089

Elastomeric Infusion Pumps Market

Published:
Report ID: 4996

Emergency Hospital Bed Market

Published:
Report ID: 35082

Elder Care Product Market

Published:
Report ID: 35079

Wound Care Market

Published:
Report ID: 6983

Companion Diagnostics Market

Published:
Report ID: 3964

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN